Company

DarioHealth Corp.

Headquarters: Caesarea, Israel

Employees: 200

CEO: Mr. Erez Raphael

NASDAQ: DRIO -0.23%

Market Cap

$44.4 Million

USD as of Jan. 1, 2024

Market Cap History

DarioHealth Corp. market capitalization over time

Evolution of DarioHealth Corp. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of DarioHealth Corp.

Detailed Description

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common MSK conditions; Dario's behavioral health solution that optimizes access to evidence-based care; chronic condition management solutions; DarioEngage, a proprietary care management platform; and device-specific disposables test strip cartridges, lancets, and blood glucose monitoring systems. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and diabetes management programs, including lifestyle changes, healthy eating, advanced tracking, and live coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

DarioHealth Corp. has the following listings and related stock indices.


Stock: NASDAQ: DRIO wb_incandescent

Details

Headquarters:

8 HaToKhen Street

Caesarea Industrial Park

Caesarea, 3088900

Israel

Phone: 972 4 770 4055